期刊文献+

表观遗传新标志物5hmC的研究进展 被引量:4

Research Advances on The New Epigenetic Marker: 5-Hydroxymethylcytosine
下载PDF
导出
摘要 5-羟甲基胞嘧啶(5-hydroxymethylcytosine,5hmC)作为表观遗传的新标志物,已引起人们的极大兴趣.5hmC由TET家族酶催化氧化5-甲基胞嘧啶(5-methylcytosine,5mC)产生,被称为高等生物基因组DNA的"第六碱基".5hmC不仅可以影响基因组结构及功能,还在早期胚胎发育中发挥重要的作用.本文综述了5hmC的代谢通路、生物学功能、在基因组的分布及分析方法的研究进展. Recently, the new epigenetic marker, 5-hydroxymethylcytosine (5hmC) has been widely studied. 5hmC derived from the enzymatic oxidation of 5-methylcytosine (5mC) by TET(ten-eleven translocation) protein family and called as the "six base" of higher organism genomic DNA. It is found that 5hmC not only influence the structure and function ofgenome, but also play an important role during early embryonic development. This review mainly discussed the research advances of 5hmC in metabolic pathways, biological function, genome distribution and analysis methods.
作者 葛苗苗 蔡春
出处 《生物化学与生物物理进展》 SCIE CAS CSCD 北大核心 2014年第9期839-850,共12页 Progress In Biochemistry and Biophysics
基金 国家自然科学基金资助项目(21375029) 广东医学院研究团队基金资助项目(TD1125)~~
关键词 5-羟甲基胞嘧啶 TET蛋白 早期胚胎发育 5-hydroxymethylcytosine, TET proteins, early embryonic development
  • 相关文献

参考文献3

二级参考文献65

  • 1江涛,赵雅度.胶质瘤的分子病理分类和靶向治疗研究[J].中华外科杂志,2006,44(18):1292-1294. 被引量:8
  • 2Mayer W, Niveleau A, Walter J, Fundele R, Haaf T. Demethylation of the zygotic paternal genome. Nature 2000; 403:501- 502.
  • 3Oswald J, Engemann S, Lane N, et al. Active demethylation of the paternal genome in the mouse zygote. Curt Bio12000; 10:475-478.
  • 4Hajkova P, Erhardt S, Lane N, et al. Epigenetic reprogramming in mouse primordial germ cells. Mech Dev 2002; 117:15-23.
  • 5Cedar H, Bergman Y. Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 2009; 10:295-304.
  • 6Sasaki H, Matsui Y. Epigenetic events in mammalian germcell development: reprogramming and beyond. Nat Rev Genet 2008; 9:129-140.
  • 7Suzuki MM, Bird A. DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 2008; 9:465- 476.
  • 8Goll MG, Bestor TH. Eukaryotic cytosine methyltransferases. Annu Rev Biochem 2005; 74:481-514.
  • 9Wu SC, Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Bio12010; 11:607-620.
  • 10Ooi SK, Bestor TH. The colorful history of active DNA demethylation. Cell 2008; 133:1145-1148.

共引文献21

同被引文献101

  • 1陈伶利,李杰,袁肇凯,瞿岳云.早发冠心病血瘀证的分子生物学研究现状和探讨[J].岭南心血管病杂志,2011,17(S1):55-56. 被引量:2
  • 2闫冰冰,李力.DNA甲基化与卵巢癌多药耐药及预后的关系[J].中国肿瘤生物治疗杂志,2015,22(3):281-289. 被引量:7
  • 3李杰,袁肇凯.冠心病血瘀证的病机研究[J].中西医结合心脑血管病杂志,2006,4(7):613-615. 被引量:43
  • 4Baylin S B, Jones P A. A decade of exploring the cancer epigenome- biological and translational implications [ J ]. Nat Rev Cancer, 2011, 11(7) : 26 -34.
  • 5Feinberg A P, Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts [J]. Nature, 1983, 301 (5895): 89-92.
  • 6Gama-Sosa M A, Slagel V A, Trewyn R W, et al. The 5-methylcytosine content of DNA from human tumors[ J]. Nucleic Acids Res, 1983, 11 (19) : 6883 -6894.
  • 7Tahiliani M, Koh K P, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1 [J]. Science, 2009, 324(5929): 930-935.
  • 8Ha_finer M C, Chaux A, Meeker A K, et al. Global 5-hydroxy methyleytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers [ J]. Oncotarget, 2011, 2(8) : 627 -637.
  • 9Jin S G, Jiang Y, Qiu R, et al. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations[J]. Cancer Res, 2011,71(24): 7360-7365.
  • 10Kraus T F, Globisch D, Wagner M, et al. Low values of 5-hydroxy- methylcytosine ( 5hmC ), the " sixth base", are associated with anaplasia in human brain tumors [ J ]. Int J Cancer, 2012, 131 (7) : 1577 - 1590.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部